Drivers and Trends in Cardiovascular Device Development: Insights from Key Opinion Leaders
The prevalence and impact of cardiovascular disease continue to grow, presenting important challenges to healthcare systems and professionals, as well as to the biotech and medical device industry. Efforts aimed at disease prevention are gaining traction in advanced nations, while the cardiovascular disease burden of an aging population in developing societies remains the primary healthcare challenge. This demographic pressure remains a key driver in advancing new technologies for diagnosis and treatment, often crossing established borders between therapeutic areas, and the pharmaceutical and medical device industries.
Our featured speakers see new trends emerging in medical device development, with particular focus on minimally invasive approaches, risk-benefit balance, multi-disciplinary strategies, and health economic factors. There is a growing demand for stronger clinical evidence supporting both existing and novel medical devices, in an environment where changing regulatory approval pathways and high cost of cardiovascular devices can play a restraining role.
In this webinar, Dr. Dean Kereiakes shares his expert views as a Key Opinion Leader on how the cardiovascular medical device world is evolving, and how this field links to daily clinical practice and research. Through panel discussion with Dr. Nicholas Alp and Danny Detiege, and through audience interaction, the goal of this webinar is to provide valuable insights into the future of medical device clinical development.